Aripiprazole is described as an atypical antipsychotic drug that is used in the therapy of schizophrenia. It is a FDA approved drug for treatment of acute manic and bipolar disorder. The drug shows its effect by working as a partial agonist at D2 receptor, thus also become an agonist of 5-HT1A receptor. Moreover, this drug is also associated with the management of major depressive disorder, tic disorder and irritability related with autism.
1-(2,3-Dichlorophenyl) Piperazine Hydrochloride is considered as one of the most important intermediated in pharmaceutical company. It is synthesized using diethanolamine that is halogenated to produce β, β’-dihalogenated diethyiammonium hydrochloride, which further get reacted to 2,3-dichloroaniline in aqueous solution. The whole processing steps are done at our state-of-the-art manufacturing unit under stable conditions.
